Part, Chapter, Paragraph
1 II, 5. 1. 2| Chronic diseases and their treatments can easily interfere with
2 II, 5. 2. 2| disease and impact of the treatments. These data, although collected
3 II, 5. 2. 2| disease and impacts of the treatments. As already explained, MONICA
4 II, 5. 2. 3| for CVD morbidity. Three treatments are recommended for IHD
5 II, 5. 2. 5| survival linked to better treatments. This highlights the importance
6 II, 5. 2. 5| monitor disease trends, treatments and risk factors in order
7 II, 5. 2. 6| or through more expensive treatments, such as invasive surgery.
8 II, 5. 2. 6| invasive and biological treatments contribute substantially
9 II, 5. 2. 7| from Modern Cardiological Treatments and Population Risk Factor
10 II, 5. 3. 7| new innovative cancer drug treatments and the importance of equal
11 II, 5. 4. 5| patterns in time and different treatments. Certain medical conditions
12 II, 5. 4. 6| timely initiation of adequate treatments. The WHO 2003 report defines
13 II, 5. 5.Int| availability of modern, effective treatments. Better policies and provision
14 II, 5. 5. 2| and access to effective treatments falls into the category
15 II, 5. 5. 2| access to currently available treatments, efficient health services,
16 II, 5. 5. 3| number of data, surveys and treatments being available. It becomes
17 II, 5. 5. 3| diagnosis and the access to treatments are necessary to enable
18 II, 5. 5. 3| structured psychosocial treatments allow a remarkable fraction
19 II, 5. 5. 3| treated although effective treatments exist) for schizophrenia
20 II, 5. 5. 3| psychotherapeutic than pharmacological treatments (Lehman et al, 2003). Apart
21 II, 5. 5. 3| untreated although effective treatments exist), the median treatment
22 II, 5. 5. 3| provision of psycho-social treatments in routine care, the standard
23 II, 5. 5. 3| While pharmacological treatments are extensively studied,
24 II, 5. 5. 3| the everyday use of these treatments, because the study population
25 II, 5. 5. 3| especially big for psychosocial treatments. Although there are indications
26 II, 5. 5. 3| C (2002): Psychological treatments in schizophrenia: I. Meta-analysis
27 II, 5. 5. 3| approach in relation to treatments, therapies and services,
28 II, 5. 5. 3| comparison of immunomodulatory treatments and dose issues. All these
29 II, 5. 5. 3| good practice review of MS treatments and therapies, reviewing
30 II, 5. 5. 3| medications and surgical treatments currently available help
31 II, 5. 6. 4| expensive and widespread treatments for rheumatoid arthritis
32 II, 5. 7. 1| cost of renal replacement treatments are still in an expanding
33 II, 5. 7. 5| Statistical Yearbook of Dialysis Treatments) is organized by the Czech
34 II, 5. 11. 3| can be managed with simple treatments. In a study of 695 school
35 II, 5. 11. 7| Overview of studies of treatments for hand eczema – the EDEN
36 II, 6. 3. 3| practices (tattooing, beauty treatments, etc.) are still important
37 II, 6. 4. 5| antimicrobial agents, alternative treatments and vaccines; b) support
38 II, 7. 5 | surveys), and other medical treatments (household surveys such
39 II, 8. 2. 1| disadvantaged as dental or medical treatments may be withdrawn due to
40 II, 9. 1. 2| Developments in surgical treatments and neonatal intensive care
41 II, 9. 1. 2| towards developing drug treatments for genetic diseases. Full
42 II, 9. 1. 2| development of non-drug treatments e.g. improved shunts for
43 II, 9. 3. 2| can conceive, but these treatments increase multiple births –
44 II, 9. 4. 3| focus on finding suitable treatments for this group or clarify
45 II, 9. 5. 3| differences in access to specific treatments such as psychotherapy or
46 II, 9. 5. 3| and in the response to treatments and their outcomes. Female
47 III, 10. 2. 1| medications and behavioral treatments for tobacco addiction (NID ~ ~
48 III, 10. 2. 1| nicotine. The available treatments for nicotine addiction show
49 III, 10. 2. 1| individuals exposed to these treatments, especially when delivered
50 III, 10. 2. 1| the effectiveness of these treatments tends to be comparable regardless
51 III, 10. 2. 1| analysis of clinical trials of treatments for alcohol use disorders.
52 III, 10. 2. 1| treatment adds to other types of treatments including abstinence oriented
53 III, 10. 2. 1| regarding the accessibility of treatments in some regions.~The description
54 IV, 11. 1. 5| when particular tests and treatments should be used for specific
55 IV, 11. 1. 5| rates or specific disease treatments (as for coronary heart disease
56 IV, 11. 1. 6| diagnoses, severity and treatments. There is concern over how
57 IV, 11. 2. 2| pharmaceutical and psycho-social treatments continues to grow, there
58 IV, 11. 3. 1| increasing complexity of medical treatments (Simoens and Hurst, 2006)
59 IV, 11. 5. 4| transplantation are medical treatments that require the full participation
60 IV, 12. 2 | individuals exposed to these treatments, especially when delivered
61 IV, 12. 2 | the effectiveness of these treatments tends to be comparable regardless
62 IV, 12. 10 | financial support to infertility treatments.~ ~ ~ ~National Programme
